Search Results - "Simkovic M"

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Authors: Molica, Stefano Scalzulli, Potito Rosario Scarfò, Lydia et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p1000. 14p.

Author Index.

Source: Higher Education Abstracts. Jul2021, Vol. 56 Issue 3, p305-308. 4p.

Subject Terms: *Authors

Chlorination of Phenethyl Isothiocyanate Potentiates Cytotoxicity and Apoptosis in Multidrug-Resistant Leukemia Cells.

Authors: Yoldi Vergara, Alberto Bertova, Anna Kontar, Szilvia et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5869. 26p.

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies.

Authors: Meza, Kelly Barrientos Risso, Carla Shah, Ankit et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p5117. 18p.

Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia—A KroHem Study.

Authors: Mandac Smoljanović, Inga Aurer, Igor Bulj, Nikola et al.

Source: Cancers. Jul2025, Vol. 17 Issue 14, p2302. 15p.

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk.

Authors: Andreescu, Mihaela Tudorache, Sorin Ioan Moldovan, Cosmin Alec et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1621. 18p.

Real-World Safety of Acalabrutinib in Mexico: A Postmarketing Surveillance Study.

Authors: Ishikawa-Ichikawa, Akemi Islas-Martínez, Jorge Alberto Rios-Garcia, Eduardo et al.

Source: Pharmacoepidemiology (2813-0618). Mar2026, Vol. 5 Issue 1, p7. 12p.

Efficacy of Pirtobrutinib Monotherapy in Treatment-Naïve Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors: Eyre, Toby A. Hess, Lisa M. Masoudi, Ehsan et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p660. 15p.

Prognostic Impact of Serum Albumin Levels at Diagnosis in Patients with Chronic Lymphocytic Leukemia.

Authors: Küçükyurt Kaya, Selin Afacan Öztürk, Hacer Berna Koca, Oguzhan et al.

Source: Journal of Clinical Medicine. Feb2026, Vol. 15 Issue 3, p1315. 11p.

Nanomechanical and Thermodynamic Alterations of Red Blood Cells in Chronic Lymphocytic Leukemia: Implications for Disease and Treatment Monitoring.

Authors: Strijkova, Velichka Katrova, Vesela Ivanova, Miroslava et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p353. 21p.

Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report.

Authors: Ecsiova D Kamaradova K Nova M et al.

Source: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia [Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub] 2023 Dec; Vol. 167 (4), pp. 385-389. Date of Electronic Publication: 2022 Jun 15.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Vydavatelství Univerzity Palackého Country of Publication: Czech Republic NLM ID: 101140142 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1804-7521 (Electronic) Linking ISSN: 12138118 NLM ISO Abbreviation: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Subsets: MEDLINE

IS THE CORPORATE SOLVENCY CONUNDRUM PRIMARILY AN BALKAN ISSUE OR A BROADER EUROPEAN CONTINENTAL MISUNDERSTANDING?

Authors: Pavlović, Vladan Knežević, Goranka Callado, Antônio André Cunha

Source: Economic Studies. 2022, Vol. 31 Issue 1, p72-93. 22p.

Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis.

Authors: Alatawi, Yasser Alanazi, Fawaz E. Alattar, Abdullah et al.

Source: Pharmaceuticals (14248247). Nov2025, Vol. 18 Issue 11, p1674. 21p.

This result is not displayed to guests.
Login for full access.

Author Index.

Source: FEBS Journal. Jun2008 Supplement, Vol. 275, p471-488. 18p.

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.

Authors: Mauro, Francesca Romana Scalzulli, Potito Rosario Scarfò, Lydia et al.

Source: Cancers. Mar2024, Vol. 16 Issue 6, p1228. 15p.

A STUDY OF GRAMMATICAL ERRORS WHEN USING TRANSLATION SOFTWARE FOR STUDENTS IN ECONOMIC CONTRACTS.

Alternate Title: UM ESTUDO DOS ERROS GRAMATICAIS NA UTILIZAÇÃO DE SOFTWARE DE TRADUÇÃO PARA ESTUDANTES DE CONTRATOS ECONÔMICOS.

Authors: Vo Tu Phuong¹ votuphuong@ukh.edu.vn

Source: Conhecimento & Diversidade. jan-mar2024, Vol. 16 Issue 41, p330-346. 17p.

Advancing Immunotherapy in Chronic Lymphocytic Leukemia.

Authors: Bieliński, Krzysztof Wysocka, Agnieszka Tyrna, Dawid et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p3722. 29p.

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.

Authors: Ye, Qiying Ma, Siming

Source: Molecules. Apr2026, Vol. 31 Issue 8, p1272. 29p.

Monitoring Overall Survival in Phase 3 Indolent Cancers: An Extended Framework and an Example.

Authors: Lu, Kaifeng Li, Xiaoyun Tian, Hong et al.

Source: Statistics in Biopharmaceutical Research. Apr-Jun2026, Vol. 18 Issue 2, p221-229. 9p.